Cubicin Rf: Medgend

Cubicin Rf FDA Approved Drugs

CUBICIN [Daptomycin^{C₇₂H₁₀₁N₁₇O₂₆}]

500mg/vial (intravenous powder)

Cubist Pharms Llc^{Sep 12, 2003}

Treatment of the following infections: complicated skin and skin structure infections and staphylococcus aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CUBICIN RF [Daptomycin^{C₇₂H₁₀₁N₁₇O₂₆}]

500mg/vial (intravenous powder)

Cubist Pharms Llc^{Jul 6, 2016}

Treatment of the following infections: complicated skin and skin structure infections and staphylococcus aureus bloodstream infections (bacteremia) including those with right-sided infective endocarditis.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

DAPTOMYCIN [Daptomycin^{C₇₂H₁₀₁N₁₇O₂₆}]

500mg/vial (intravenous powder)

Crane Pharms Llc^{Jun 15, 2016}
Hospira Inc^{Sep 12, 2014}
Teva Parenteral^{Mar 25, 2016}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.